These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2086018)

  • 21. [Clinical effect and laboratory observation of ofloxacin in the treatment of typhoid fever, bacillary dysentery and gonorrhea].
    Zou QY; Wang QN; Jiang YF
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):572-4, 596. PubMed ID: 1806341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
    Moolasart P; Eampokalap B; Ratanasrithong M
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):764-9. PubMed ID: 10928373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial susceptibilities of Shigella dysenteriae type 1 isolated in Zimbabwe--implications for the management of dysentery.
    Mason PR; Nathoo KJ; Wellington M; Mason E
    Cent Afr J Med; 1995 Apr; 41(4):132-7. PubMed ID: 7788685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled clinical trial of trimethoprim-sulphamethoxazole in shigella dysentery.
    Mabadeje AF
    J Trop Med Hyg; 1974 Mar; 77(3):50-4. PubMed ID: 4598139
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the stability of antibiotic resistance of Shigella sonnei in epidemiologic practice].
    Sivolodskiĭ EP
    Antibiotiki; 1974 Dec; 19(12):1117-1120. PubMed ID: 4614700
    [No Abstract]   [Full Text] [Related]  

  • 28. CTX-M-3 type beta-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases.
    Acikgoz ZC; Eser OK; Kocagöz S
    Jpn J Infect Dis; 2008 Mar; 61(2):135-7. PubMed ID: 18362404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic resistance of Shigella, isolated during 1966-1967, in some populated areas of Central Povolozh'e and their comparative characteristics at a 10 year interval].
    Blokhov VP; Raĭgorodskaia AG
    Antibiotiki; 1969 Dec; 14(12):1110-1. PubMed ID: 4905939
    [No Abstract]   [Full Text] [Related]  

  • 30. Shigella and Salmonella serogroups and their antibiotic susceptibility patterns in Ethiopia.
    Asrat D
    East Mediterr Health J; 2008; 14(4):760-7. PubMed ID: 19166157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High percentage of antibiotic resistance in Shigella infections in children in Curaçao].
    Wolfs TF; van Woensel JB; Muskiet FD
    Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2510-3. PubMed ID: 9005333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of antimicrobial-resistant shigellosis in Oregon.
    Replogle ML; Fleming DW; Cieslak PR
    Clin Infect Dis; 2000 Mar; 30(3):515-9. PubMed ID: 10722437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Importance of the R-factor for the epidemiology of Shigella sonnei].
    Tschäpe H; Rische H
    Z Gesamte Hyg; 1970 Sep; 16(9):662-4. PubMed ID: 4920715
    [No Abstract]   [Full Text] [Related]  

  • 34. Changing patterns of the prevalence of different Shigella species and their antibiotic susceptibilities in Ankara, Turkey.
    Ceyhan M; Akan O; Kanra G; Ecevit Z; Seçmeer G; Berkman E
    J Diarrhoeal Dis Res; 1996 Sep; 14(3):187-9. PubMed ID: 9019012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study on norfloxacin in pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1990 May; 43(5):837-41. PubMed ID: 2391754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic sensitivity of 299 strains of shigella isolated in Burundi].
    Ndihokubwayo JB; Baribwira C; Ndayiragije A; Poste B
    Med Trop (Mars); 1996; 56(1):37-40. PubMed ID: 8767790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hospital epidemics of dysentery caused by an infection-resistant strain of Shigella sonnei].
    Klucár E; Cervinka K; Krcmery V
    Cesk Epidemiol Mikrobiol Imunol; 1973 May; 22(3):149-52. PubMed ID: 4268254
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shigella-associated diarrhea in children in South Jakarta, Indonesia.
    Herwana E; Surjawidjaja JE; Salim OCh; Indriani N; Bukitwetan P; Lesmana M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):418-25. PubMed ID: 20578526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.